-
June 16, 2026
Sanofi-Aventis US deceives customers into believing its Qunol liquid CoQ10 supplements have "superior absorption" advantages compared to regular CoQ10 products despite scientific testing that shows otherwise and prior legal action that barred it from making similar efficacy claims, alleges a proposed class action filed Monday in New Jersey federal court.
-
June 16, 2026
Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties.
-
June 16, 2026
A Delaware federal judge on Tuesday upheld a jury's 2023 verdict finding that Guardant Health Inc. should pay TwinStrand Biosciences Inc. $83.4 million for willfully infringing diagnostic patents, refusing to overturn or enhance the award.
-
June 16, 2026
The U.S. Securities and Exchange Commission announced on Tuesday that a Texas-based investor will pay over $240,000 to settle the agency's claims he improperly traded stocks on insider information by buying shares of a public biotech firm ahead of its 2020 merger with a privately held biotechnology company.
-
June 16, 2026
Cigna "improperly asserted privilege" over hundreds of documents that three laboratories sought as part of the discovery process in federal payment litigation in Connecticut, according to a special master appointed by the judge in the consolidated cases.
-
June 16, 2026
A Delaware federal judge on Tuesday permitted Pfizer and Moderna to move ahead with their arguments that GlaxoSmithKline patents the company claims are infringed by the COVID-19 vaccines are unenforceable because of an unreasonable delay in obtaining them.
-
June 16, 2026
A mistrial was declared Monday by a Los Angeles state judge in a two-month trial over allegations Johnson & Johnson's talc products caused a woman's deadly mesothelioma after the jury deadlocked during deliberations, according to counsel for the plaintiff.
-
June 16, 2026
U.S. District Judge Brendan Abell Hurson in Baltimore has been on the bench for less than three years, but he's already building an impressive list of healthcare rulings, with the latest one blocking portions of federal regulations on the Affordable Care Act exchanges.
-
June 16, 2026
The plaintiffs in the multidistrict litigation accusing Pfizer of failing to warn consumers of a link between brain tumors and the hormonal contraceptive Depo-Provera have reached an agreement with the pharmaceutical giant, according to an order filed Monday.
-
June 15, 2026
The U.S. Department of Justice urged a New York federal court Monday to deny a request for an order barring the government from seeking transgender minor patients' medical records through a criminal subpoena issued by a Texas grand jury, arguing the court lacks jurisdiction.
-
June 15, 2026
U.S. Patent and Trademark Office Director John Squires has granted five patent challenges and rejected seven others, and he also issued a decision Monday explaining why he allowed a group of Tesla petitions to go ahead to the merits stage of review.
-
June 15, 2026
Jurors have cleared the University of Washington's medical school of liability in an anesthesiology professor's lawsuit alleging that she was unfairly ousted from a director role after complaining of discrimination and harassment, finding that the professor failed to sufficiently prove any of her three claims against the school.
-
June 15, 2026
The Federal Trade Commission's third and final settlement resolving an in-house case accusing pharmacy benefit managers of inflating insulin prices through rebate schemes is in sight after the agency on Friday pulled from adjudication its allegations against UnitedHealth Group Inc.'s OptumRx to review a deal struck with staffers.
-
June 15, 2026
Genetic testing company Invitae Corp. has been hit with proposed class privacy claims by an Illinois parent who says the company unlawfully disclosed its patients' genetic information to LabCorp after the laboratory testing giant bought Invitae out of bankruptcy.
-
June 15, 2026
CareFirst is arguing that a Virginia federal judge created a new standard for monopolization claims when he dismissed claims from the company's antitrust suit challenging Johnson & Johnson's protection of its immunosuppressive drug Stelara, arguing he misread a Fourth Circuit decision in ruling that monopolization requires a showing of specific intent.
-
June 15, 2026
An Illinois appellate panel has thrown out a $60 million jury verdict awarded to a mother claiming Mead Johnson's infant formula caused her premature baby to develop a fatal gut disease, saying the trial court erred in finding the company owed a duty to warn the mother and not just the infant's doctors, and allowing prejudicial evidence about Mead Johnson's profits.
-
June 15, 2026
A Wyoming judge has struck down three state laws restricting abortion care, finding that the state failed to demonstrate it had a compelling interest in effectuating a 48-hour waiting period for abortions and requiring certain abortion facilities to be licensed as ambulatory surgical centers, among other restrictions.
-
June 15, 2026
Medical imaging company Nano-X Imaging Ltd. faces a proposed investor class action alleging it failed to tell investors that it had expanded its manufacturing operations beyond what customer demand justified, ultimately leading to a $17.5 million write-down.
-
June 15, 2026
Hagens Berman Sobol Shapiro LLP must cover the fees and costs of a special master who alleged the firm committed misconduct in product liability litigation over the morning sickness drug thalidomide, a Pennsylvania federal judge has said.
-
June 15, 2026
An attorney and stockholder in the former Mylan NV objected to the attorneys' fees in a proposed $60 million class action settlement, telling a Pennsylvania federal judge Monday that the plaintiffs' lawyers effectively "lost" a suit that began with allegations of $5.1 billion in lost share value.
-
June 15, 2026
A California federal judge has given the first green light to a $69 million settlement reached between investors and ChemoCentryx, resolving claims that the California-based pharmaceutical company overstated the efficacy of its newly developed treatment for autoimmune disease ANCA vasculitis.
-
June 12, 2026
A Delaware federal jury decided Friday that Amgen Inc. and its Teneobio Inc. unit willfully infringed a mouse antibody patent asserted by Harbour Antibodies BV and others, and should pay $20.2 million in damages — the full amount Harbour was seeking.
-
June 12, 2026
A long-running dispute over whether Johnson & Johnson's baby powder caused the cancer that killed a Miami anesthesiologist concluded with a settlement just before closing arguments in a second trial after the first ended in a hung jury.
-
June 12, 2026
Disability rights organizations hit the governors of New York and Illinois with a pair of federal lawsuits seeking to stop new laws in each state from taking effect that would allow patients with terminal illnesses to seek a doctor's assistance in ending their lives.
-
June 12, 2026
Directors and officers of animal health company Zoetis Inc. have been hit with shareholder derivative claims that they breached their fiduciary duties by concealing that safety warnings about one of its products and increasing competition were hurting the company's bottom line.